Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Morningstar report on TD Waterhouse
View:
Post by money4golf on Sep 29, 2024 7:49pm

Morningstar report on TD Waterhouse

I like reading this instead of watching TD and Scotia seemingly bring the price down....
This is on the TD Waterhouse website last report.
 
Quantitative Equity Research Report | Release: 27 Sep 2024, 02:58 UTC | Reporting Currency: CAD | Trading Currency: CAD | Exchange: TORONTO STOCK EXCHANGE
Spectral Medical Inc EDT QQQ Q 26 Sep 2024 22:40, UTC
Fair Value $1.62
Valuation as of 26 Sep 2024
Morningstar affirms a 3-star quantitative rating for
Spectral Medical. We calculate this outcome using
the company's underlying model-driven valuation
and uncertainty scores.
The stock's last closing price was 0.62, a discount
of 58.76% to its Quantitative Fair Value estimate of
$1.50.
Comment by money4golf on Oct 04, 2024 10:03pm
Must be alot of work to keep supressing the share price! AP is probably right, one more round of financing.... Valuation as of 3 Oct 2024 Spectral Medical achieves a 3-star quantitative star rating based on Morningstar's equity model. This reflects the company's valuation and uncertainty scores under this assessment system. The Quantitative Fair Value estimate is 1.72, above the previous ...more  
Comment by mercedesman on Oct 06, 2024 9:52am
All good info and fair points.  Range bound price controls appear to still be in effect for whatever reason (eg last round of financing approaching with associated handouts, continued and deliberate effort in staying off the radar until Baxter CG does there thing, etc. )  The FUD group still has a small but diminshing role to play in this regard.  3 months from ETA on Top Line ...more  
Comment by Spamme54321 on Oct 06, 2024 9:04pm
MM, Please keep your bromance behind close doors, we dont want to hear about your disgusting love life. Also quantative analysis does not work with a stock that trades for less than a house in the GTA on most days.
Comment by BlueJays9293 on Oct 06, 2024 9:08pm
6 more placebos, and 12 more PMX'ers, until the train leaves the station forever. Best of luck to all of you adventurers!
Comment by mercedesman on Oct 06, 2024 9:53pm
This post has been removed in accordance with Community Policy
Comment by Stocktree on Oct 07, 2024 1:57pm
- When an average is only good to point out on low months - When you follow your predictions with, "I suspect" - When you always predict magic new beginnings due to materialize in a non descript future - When you apply technical analysis to off-the-market stocks - When none of your predictions, except pick up trends that follow yearly lows, have materialized and you constantly move ...more